Written questions by Evans.

Whether national guidance has been issued to Integrated Care Boards on the prescribing of fezolinetant following its approval for NHS use.

Awaiting answer.

What guidance exists on shared care arrangements for patients seeking to transition from privately obtained medication to NHS prescriptions where those treatments later become available on the NHS.

Awaiting answer.

Whether he has had discussions with NHS England on access to fezolinetant within Leicester, Leicestershire and Rutland Integrated Care Board.

Awaiting answer.

What assessment he has made of levels of regional variation in access to fezolinetant across England.

Awaiting answer.

Pursuant to WPQ 106603 answered on 26 January 2026 about Marriage Relatives, what recent discussions the National Disease Registration Service has had with hospital trusts on improve the quality and completeness of data arising from health issues due to first cousin marriage.

Awaiting answer.

To ask the Secretary of State for Health and Social Care, with reference to the Prime Minister's oral contribution of 29 April 2026, official report, Volume 784, column 895, what is the evidential

Awaiting answer.

If he will hold discussions with (a) local and national health bodies, (b) academics and (c) the Men's Health Strategy Stakeholder Group on the issues surrounding Anabolic Steroids, IPEDs and SARMS

Awaiting answer.

What recent steps he has taken to support the national rollout of the Leukaemia Best Practice Timed Pathway.

Awaiting answer.

Pursuant to WPQ 9089 answered on 19 June 2026 about Steroid Drugs: Young People, if he will hold discussions with [i] local and national health bodies, [ii] academics and [iii] the Men's Health Str

Awaiting answer.

What the planned timetable is for the complete conclusion of the review of the Carr-Hill formula, and the publication of its findings.

Phase 1 of the Carr-Hill review concluded in May 2026. The report and recommendations are currently with the Department for consideration. The review’s findings and recommendations will be published in due course by the National Institute for Health and C...

When he expects the National Institute for Health and Care Research to publish findings from phase one of the Carr-Hill review.

Phase 1 of the Carr-Hill review concluded in May 2026. The report and recommendations are currently with the Department for consideration. The review’s findings and recommendations will be published in due course by the National Institute for Health and C...

Pursuant to WPQs 2849, 2850 and 2851 answered on 9 June 2026 about Steroid Drugs: Young People, if he will have discussions with the Secretary of State for Science, Innovation and Technology on con

Awaiting answer.

Pursuant to WPQs 2849, 2850 and 2851 answered on 9 June 2026 about Steroid Drugs: Young People, if he will have discussions with UK Anti Doping on the findings of their 2026 Clean Sport Survey on t

Awaiting answer.

Pursuant to WPQs 2849, 2850 and 2851 answered on 9 June 2026 about Steroid Drugs: Young People, if he will ensure that issues surrounding Anabolic Steroids, IPEDs and SARMs are included in work to

The UK Health Security Agency published a national Syphilis Response Plan in March 2026, which is available at the following link:https://www.gov.uk/government/publications/syphilis-public-health-england-action-plan/ukhsa-syphilis-response-planThe plan fo...

What assessment his Department has made of the compatibility of minimum waiting time policies with the NHS Constitution for England, including patients’ rights to access services within maximum wai

There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...

What guidance NHS England has issued to Integrated Care Boards on the use of minimum waiting times; and whether prior approval is required before such policies are implemented.

There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...

If he will list the integrated care boards that have implemented policies involving minimum waiting times for NHS treatment.

There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...

What data is held by NHS England on the use and impact of minimum waiting time policies across Integrated Care Boards; and whether this information is collected centrally.

There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...

For which procedures, treatments or clinical pathways minimum waiting times have been applied by Integrated Care Boards; and what criteria are used to determine their application.

There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...

What assessment he has made of the potential risk that pharmaceutical companies could withdraw compassionate access programmes due to VAT-related financial pressures.

The Government recognises the important role that compassionate and expanded access programmes can play in enabling patients, particularly those with serious or rare conditions, to access innovative medicines outside routine commissioning arrangements.VAT...